共 48 条
[11]
2-3
[15]
Dunford JE, 2002, BONE, V30, p40S
[16]
Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
[17]
EBETINO FH, 2002, BONE, V30, P40
[19]
Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1999, 96 (01)
:133-138